Alto Neuroscience, Inc. (ANRO)

NYSE: ANRO · Real-Time Price · USD

17.80

-0.14 (-0.78%)

At close: Dec 31, 2025, 4:00 PM EST

17.72

-0.08 (-0.45%)

After-hours: Dec 31, 2025, 7:00 PM EST

Alto Neuroscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-62.26	-61.43	-36.31	-27.71	-9.19
Depreciation & Amortization	0.67	0.5	0.37	0.34	0.15
Loss (Gain) From Sale of Assets	0.19	0.05	0.14	-	-
Asset Writedown & Restructuring Costs	0.74	0.74	-	-	-
Stock-Based Compensation	7.73	7.63	2.89	1.76	0.23
Other Operating Activities	1.63	1.03	0.15	0.63	0.13
Change in Accounts Receivable	-	-	-	1.16	-1.29
Change in Accounts Payable	-0.24	0.52	-0.63	1.01	0.46
Change in Other Net Operating Assets	-1.72	3.54	-0.07	2.42	0.26
Operating Cash Flow	-53.27	-47.42	-33.45	-20.39	-9.26
Capital Expenditures	-0.53	-2.08	-0.47	-0.73	-0.68
Investing Cash Flow	-0.53	-2.08	-0.47	-0.73	-0.68
Long-Term Debt Issued	-	1.25	-	9.83	-
Net Debt Issued (Repaid)	10.73	1.25	-	9.83	-
Issuance of Common Stock	0.4	137.77	0.18	0.04	0.01
Other Financing Activities	-1.18	-3.33	-2.05	-0.34	-0.21
Financing Cash Flow	9.94	135.69	68.13	43.79	31.69
Foreign Exchange Rate Adjustments	-0.02	-0.01	-0.01	-0.02	-0.05
Net Cash Flow	-43.89	86.18	34.2	22.64	21.7
Free Cash Flow	-53.8	-49.5	-33.92	-21.13	-9.94
Free Cash Flow Margin	-	-	-	-	-4734.29%
Free Cash Flow Per Share	-1.99	-2.01	-9.09	-6.13	-4.12
Cash Interest Paid	1.48	1	0.91	-	-
Levered Free Cash Flow	-36.61	-32.29	-23.45	-12.3	-
Unlevered Free Cash Flow	-35.22	-31.44	-22.6	-12.3	-
Change in Working Capital	-1.97	4.06	-0.7	4.58	-0.57

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q